Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 2, 2007, Pages

  Panning, Marcus ^a   Laue, Thomas ^b   Ölschlager, Stephan ^a   Eickmann, Markus ^c   Becker, Stephan ^c   Raith, Sabine ^b   Courbot, Marie Claude Georges ^e   Nilsson, Mikael ^f   Gopal, Robin ^g   Lundkvist, Ake ^f   Di Caro, Antonino ^h   Brown, David ^g   Meyer, Hermann ^d   Lloyd, Graham ^g   Kümmerer, Beate M ^a   Günther, Stephan ^a   Drosten, Christian ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b QIAGEN GMBH   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^e Institut Pasteur   (France)

^f Swedish Institute for Communicable Infectious Disease Control   (Sweden)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSAFETY; CONFERENCE PAPER; CONTROLLED STUDY; EBOLA VIRUS; FILOVIRUS; GENE PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN; ANALYTICAL EQUIPMENT; ANIMAL; ARTICLE; CERCOPITHECUS; EUROPE; FILOVIRIDAE; GENETICS; HAPLORHINI; HUMAN; ISOLATION AND PURIFICATION; LABORATORY; METHODOLOGY; REPRODUCIBILITY; SAFETY; SENSITIVITY AND SPECIFICITY; STANDARD; VERO CELL; VIRUS INFECTION;

PRIMER DNA;

ANIMALS; CERCOPITHECUS AETHIOPS; DNA PRIMERS; EUROPE; FILOVIRIDAE; FILOVIRIDAE INFECTIONS; HAPLORHINI; HUMANS; LABORATORIES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAFETY; SENSITIVITY AND SPECIFICITY; VERO CELLS;

EID: 38449116925     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520600     Document Type: Conference Paper

References (15)

1. Formenty P, Leroy EM, Epelboin A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006; 42:1521-6.
2. Drosten C, Kummerer BM, Schmitz H, Gunther S. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res 2003; 57:61-87.
3. Niedrig M, Schmitz H, Becker S, et al. First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol 2004; 42:1753-5.
4. Drosten C, Weber M, Seifried E, Roth WK. Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening. Transfusion 2000; 40:718-24.
5. Drosten C, Gottig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002; 40:2323-30.
6. Sanchez A, Ksiazek TG, Rollin PE, et al. Detection and molecular characterization of Ebola viruses causing disase in human and non-human primates. J Infect Dis 1999; 179(Suppl 1):S164-9.
7. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41.
8. Leroy EM, Baize S, Lu CY, et al. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 2000; 60:463-7.
9. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355:2210-5.
10. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355:909-19.
11. Towner JS, Khristova ML, Sealy TK, et al. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006; 80:6497-516.
12. Drosten C, Chiu LL, Panning M, et al. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2004; 42:2043-7.
13. Drosten C, Doerr HW, Lim W, Stohr K, Niedrig M. SARS molecular detection external quality assurance. Emerg Infect Dis 2004; 10:2200-3.
14. Niedrig M, Meyer H, Panning M, Drosten C. Follow-up on diagnostic proficiency of laboratories equipped to perform orthopoxvirus detection and quantification by PCR: the second international external quality assurance study. J Clin Microbiol 2006; 44:1283-7.
15. Niedrig M, Linke S, Zeller H, Drosten C. First international proficiency study on West Nile virus molecular detection. Clin Chem 2006; 52:1851-4.